Acorda Therapeutics Inc (NASDAQ:ACOR)

23.90
BATS BZX Real-Time Price
As of 11:29am ET
 +0.35 / +1.49%
Today’s Change
13.60
Today|||52-Week Range
29.60
+11.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.2B

Company Description

Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders. The company's two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. Acorda Therapeutics was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.

Contact Information

Acorda Therapeutics, Inc.
420 Saw Mill River Road
Ardsley New York 10502
P:(914) 347-4300
Investor Relations:

Employees

Shareholders

Mutual fund holders56.92%
Other institutional53.47%
Individual stakeholders34.43%

Top Executives

Ronald CohenPresident, Chief Executive Officer & Director
Andrew R. BlightChief Scientific Officer
Richard P. BatyckyChief Technology Officer
Burkhard BlankChief Medical Officer
William DollardSenior Director-Manufacturing